Heart Valve Lesions In The Antiphospholipid Syndrome

Author(s): Ricard Cervera, Gerard Espinosa

Journal Name: Current Rheumatology Reviews

Volume 8 , Issue 3 , 2012

Become EABM
Become Reviewer


The antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence of antiphospholipid antibodies (aPL), hypercoagulability leading to vascular thrombosis, and pregnancy morbidity. Since its recognition, a great number of cardiac manifestations have been reported in association with these antibodies, but heart valve abnormalities are the most common cardiac manifestations of the syndrome. They include valve thickness >3 mm, localized thickening involving the leaflet’s proximal or middle portion, and/or irregular nodules on the atrial face of the edge of the mitral valve, and/or the vascular face of the aortic valve. A consensus committee recommended anticoagulation in symptomatic valvular disease. Asymptomatic patients should be prophylactically treated with aspirin.

Keywords: Antiphospholipid antibodies, anticardiolipin antibodies, lupus anticoagulant, systemic lupus erythematosus.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [161 - 165]
Pages: 5
DOI: 10.2174/157339710803140210193810
Price: $65

Article Metrics

PDF: 4